New details have emerged about the progress of work on the Russian HIV vaccine.
The details were shared by the head of the Gamaleya Research Center of Epidemiology and Microbiology, Alexander Ginzburg.
Russian medical scientists are developing a vaccine against the human immunodeficiency virus (HIV) based on artificial antigen technology, Interfax reports.
Ginzburg hopes that the work will bear fruit and that in 2–3 years an effective vaccine against HIV will appear in Russia and the world.
In addition, domestic specialists are working on vaccines that have pandemic potential.
Scientists are creating so-called "vaccine preserves" in case of a pandemic.
A vaccine against Ebola fever has already been created and successfully tested, Gintsburg said.
The drug was developed using technology that was previously used in the development of the Sputnik-V coronavirus vaccine.
